Hyaluronic Acid-modified Liposomes for Ursolic Acid-targeted Delivery Treat Lung Cancer Based on p53/ARTS-mediated Mitochondrial Apoptosis
Iranian Journal of Pharmaceutical Research · 07.04.2023 · 22 (1)
DOI: 10.5812/ijpr-131758 ↗Kurz gefasst
Fachartikel in der Zeitschrift Iranian Journal of Pharmaceutical Research, online erschienen am 07.04.2023. Verfasst von TingTing Ma und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Ningbo Yinzhou No.2 Hospital, Ningbo, China. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Chemotherapy drugs can cause drug resistance and other problems when treating lung cancer, which leads to treatment failure. Ursolic acid (UA) is used in formulations based on traditional Chinese medicine. UA has excellent anti-tumor effects, but they are limited by solubility and non-specificity to tumor cells.
Objectives
To overcome these issues, we created a novel hyaluronic acid (HA)-targeted liposome system for delivering UA (HA-Lipo/UA) to explore the targeting and anti-tumor effects of UA.
Methods
We constructed the HA-Lipo/UA delivery system by the thin film hydration method. The uptake and localization of UA were detected by flow cytometry and microscope. Cell proliferation of A549 cells was detected by MTT assays. Apoptosis and reactive oxygen species (ROS) expression of A549 cells were also evaluated after being treated with HA-Lipo/UA. Western blot analysis evaluated the anti-tumor mechanism of HA-Lipo/UA.
Results
HA-Lipo/UA exhibited favorable targeting of the cluster of differentiation (CD)44-overexpressing A549 cells. HA-Lipo/UA exhibited significant inhibition of the proliferation of A549 cells and induced their apoptosis compared with the corresponding monotherapies. HA-Lipo/UA induced overexpression of reactive oxygen species and upregulated expression of p53 and apoptosis-related protein in the transforming growth factor-β signaling (ARTS) pathway, which induced cytochrome-c release, activation of caspase-3, and promoted mitochondrial apoptosis in A549 cells.
Conclusions
Taken together, these data suggested that HA-Lipo/UA could be used to target tumor cells.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Infectious Diseases, Ningbo Yinzhou No.2 Hospital, Ningbo, China.
- Department of Respiratory and Critical Care Medicine, Ningbo Yinzhou No.2 Hospital, Ningbo, China.
- The Affiliated Hospital of Medical School, University of Ningbo, Ningbo, China.
Zitieren
APA
Ma, T., Zhou, J., Li, J., & Chen, Q. (2023). Hyaluronic Acid-modified Liposomes for Ursolic Acid-targeted Delivery Treat Lung Cancer Based on p53/ARTS-mediated Mitochondrial Apoptosis. Iranian Journal of Pharmaceutical Research, 22(1). https://doi.org/10.5812/ijpr-131758
Vancouver
Ma T, Zhou J, Li J, Chen Q. Hyaluronic Acid-modified Liposomes for Ursolic Acid-targeted Delivery Treat Lung Cancer Based on p53/ARTS-mediated Mitochondrial Apoptosis. Iranian Journal of Pharmaceutical Research. 2023;22(1). doi:10.5812/ijpr-131758
BibTeX
@article{Ma2023,
author = {Ma, TingTing and Zhou, Jiasi and Li, Jiajie and Chen, Qi},
title = {Hyaluronic Acid-modified Liposomes for Ursolic Acid-targeted Delivery Treat Lung Cancer Based on p53/ARTS-mediated Mitochondrial Apoptosis},
journal = {Iranian Journal of Pharmaceutical Research},
year = {2023},
volume = {22},
number = {1},
doi = {10.5812/ijpr-131758}
}
EUVIMED